Fortress Biotech, Inc. Common Stock (NASDAQ: FBIO) last traded at $2.87, up 3.61% on the session. The quote above updates while this page is open; the figures below are drawn from Fortress Biotech, Inc. Common Stock’s own filings and are restated only when a new one is published.
Fortress Biotech, Inc. Common Stock trades on NASDAQ under the ticker FBIO. Its market capitalisation is $95.60 million.
Valuation measures for Fortress Biotech, Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $95.60M |
|---|---|
| Enterprise value | $9.66M |
| P/E ratio | 1.06 |
| Price / sales | 1.40 |
| Price / book | 0.58 |
| Beta | 1.05 |
Trailing-twelve-month figures tagged in Fortress Biotech, Inc. Common Stock's XBRL filings with the SEC.
| Revenue (TTM) | $68.47M |
|---|---|
| Net income (TTM) | $111.82M |
| EPS (TTM) | $2.70 |
| Operating margin | -42.61% |
| Return on equity | 68.12% |
| Cash | $196.58M |
Range and volume for FBIO over the past 52 weeks.
| 52-week high | $4.53 |
|---|---|
| 52-week low | $2.18 |
| Volume | 202.6K |
| Average volume | 601.3K |
| Previous close | $2.77 |
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.